BioLineRx(BLRX)
搜索文档
BioLineRx(BLRX) - 2019 Q4 - Annual Report
2020-03-12 19:07
As filed with the U.S. Securities and Exchange Commission on March 12, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY ...
BioLineRx(BLRX) - 2019 Q3 - Earnings Call Transcript
2019-11-12 02:29
BioLineRx Ltd. (NASDAQ:BLRX) Q3 2019 Results Earnings Conference Call November 11, 2019 10:00 AM ET Company Participants Timothy McCarthy - IR, LifeSci Advisors Phil Serlin - CEO Mali Zeevi - CFO Abi Vainstein - VP, Clinical and Medical Affairs Conference Call Participants Joe Pantginis - HC Wainwright Mark Breidenbach - Oppenheimer Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2019 Conference Call. All participants are at present in a listen-only mode. Fol ...
BioLineRx(BLRX) - 2019 Q2 - Earnings Call Transcript
2019-08-07 03:45
BioLineRx Ltd. (NASDAQ:BLRX) Q2 2019 Results Conference Call August 6, 2019 10:00 AM ET Company Participants Timothy McCarthy - IR, LifeSci Advisors Phil Serlin - CEO Mali Zeevi - CFO Abi Vainstein - VP, Clinical and Medical Affairs Conference Call Participants Mark Breidenbach - Oppenheimer Joe Pantginis - HC Wainwright Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2019 Conference Call. All participants are at present in a listen-only mode. Following mana ...
BioLineRx(BLRX) - 2019 Q1 - Earnings Call Transcript
2019-05-15 03:48
BioLineRx Ltd. (NASDAQ:BLRX) Q1 2019 Results Earnings Conference Call May 14, 2019 10:00 AM ET Company Participants Tim McCarthy - LifeSci Advisors, IR Phil Serlin - CEO Mali Zeevi - CFO Abi Vainstein - VP, Clinical Development Ella Sorani - VP, Research and Development Conference Call Participants Joe Pantginis - HC Wainwright Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2019 Conference Call. [Operator Instructions] I would now like to turn the call over ...
BioLineRx(BLRX) - 2018 Q4 - Earnings Call Transcript
2019-03-29 01:27
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2018 Earnings Conference Call March 27, 2019 10:00 AM ET Company Participants Tim McCarthy - LifeSci Advisors, IR Phil Serlin - CEO Mali Zeevi - CFO Abi Vainstein - VP, Clinical and Medical Affairs Ella Sorani - VP, Research and Development Conference Call Participants Jason McCarthy - Maxim Joe Pantginis - HC Wainwright Mark Breidenbach - Oppenheimer Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2018 Results C ...
BioLineRx(BLRX) - 2018 Q4 - Annual Report
2019-03-28 19:08
As filed with the U.S. Securities and Exchange Commission on March 28, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY ...